¿Las vacunas anti-COVID-19 disponibles se diferencian en eficacia en personas mayores?
DOI:
https://doi.org/10.51987/revhospitalbaires.v41i1.67Palabras clave:
vacuna, covid-19, eficacia, adultos mayoresResumen
.
Descargas
Referencias
Follegati PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467-478. DOI: https://doi.org/10.1016/S0140-6736(20)31604-4
Loguniv DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet.2021;397(10275):671-681. DOI: https://doi.org/10.1016/S0140-6736(21)00234-8
Ramasamy MN, Minassian AM, Ewer KJ, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2021;396(10267):1979-1993. DOI: https://doi.org/10.1016/S0140-6736(20)32466-1
Vaccines and Related Biological Products Advisory Committee Meeting. FDA briefing document: Janssen Ad26.COV2.S vaccine for the prevention of COVID-19 [Internet]. Silver Spring, MD: FDA; 2021 Feb 21 [citado 2021 mar 18]. Disponible en: https://www.fda.gov/media/146217/download.
Voysey M, Costa Clemens SA, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020;397(10269):99-111. DOI: https://doi.org/10.1016/S0140-6736(20)32661-1
Wu Z, Hu Y, Xu M, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;S1473-3099(20)30987-7 DOI: https://doi.org/10.1016/S1473-3099(20)30987-7
Descargas
Compartir artículo
Publicado
Número
Sección
Licencia
Derechos de autor 2021 Revista del Hospital Italiano de Buenos Aires
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
